As of June 21, 2025, Celexus Inc (CXUS) reports a Gross Margin of 13.92%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Celexus Inc's Gross Margin
Over recent years, Celexus Inc's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2020-03-31 | 13.92% |
| 2019-03-31 | 13.92% |
| 2018-03-31 | -500.00% |
This steady improvement highlights how Celexus Inc manages its operational efficiency and pricing power over time.
Comparing Celexus Inc's Gross Margin to Peers
To better understand Celexus Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Celexus Inc (CXUS) | 13.92% |
| NanoSphere Health Sciences Inc (NSHS.CN) | 7775.20% |
| Sunset Island Group Inc (SIGO) | 7775.20% |
| Nouveau Life Pharmaceuticals Inc (NOUV) | 7775.20% |
| RespireRx Pharmaceuticals Inc (RSPI) | 7775.20% |
| Rise Life Science Corp (RLSC.CN) | 6291.29% |
Compared to its competitors, Celexus Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.